BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 26385769)

  • 1. Emerging Roles for RIPK1 and RIPK3 in Pathogen-Induced Cell Death and Host Immunity.
    Saleh D; Degterev A
    Curr Top Microbiol Immunol; 2017; 403():37-75. PubMed ID: 26385769
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Kinase Activities of RIPK1 and RIPK3 Can Direct IFN-β Synthesis Induced by Lipopolysaccharide.
    Saleh D; Najjar M; Zelic M; Shah S; Nogusa S; Polykratis A; Paczosa MK; Gough PJ; Bertin J; Whalen M; Fitzgerald KA; Slavov N; Pasparakis M; Balachandran S; Kelliher M; Mecsas J; Degterev A
    J Immunol; 2017 Jun; 198(11):4435-4447. PubMed ID: 28461567
    [TBL] [Abstract][Full Text] [Related]  

  • 3. RIPK3-Dependent Recruitment of Low-Inflammatory Myeloid Cells Does Not Protect from Systemic
    Satkovich J; Anderson CJ; Medina CB; Ottolini M; Lukens JR; Kendall MM
    mBio; 2020 Oct; 11(5):. PubMed ID: 33024046
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The diverse role of RIP kinases in necroptosis and inflammation.
    Silke J; Rickard JA; Gerlic M
    Nat Immunol; 2015 Jul; 16(7):689-97. PubMed ID: 26086143
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rhinovirus 3C protease suppresses apoptosis and triggers caspase-independent cell death.
    Lötzerich M; Roulin PS; Boucke K; Witte R; Georgiev O; Greber UF
    Cell Death Dis; 2018 Feb; 9(3):272. PubMed ID: 29449668
    [TBL] [Abstract][Full Text] [Related]  

  • 6. RIP kinases as modulators of inflammation and immunity.
    He S; Wang X
    Nat Immunol; 2018 Sep; 19(9):912-922. PubMed ID: 30131615
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cell Death and Inflammation - A Vital but Dangerous Liaison.
    Peltzer N; Walczak H
    Trends Immunol; 2019 May; 40(5):387-402. PubMed ID: 31003931
    [TBL] [Abstract][Full Text] [Related]  

  • 8. RIPK1 and RIPK3: critical regulators of inflammation and cell death.
    Newton K
    Trends Cell Biol; 2015 Jun; 25(6):347-53. PubMed ID: 25662614
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Complex Pathologic Roles of RIPK1 and RIPK3: Moving Beyond Necroptosis.
    Wegner KW; Saleh D; Degterev A
    Trends Pharmacol Sci; 2017 Mar; 38(3):202-225. PubMed ID: 28126382
    [TBL] [Abstract][Full Text] [Related]  

  • 10. RIPK1 can function as an inhibitor rather than an initiator of RIPK3-dependent necroptosis.
    Kearney CJ; Cullen SP; Clancy D; Martin SJ
    FEBS J; 2014 Nov; 281(21):4921-34. PubMed ID: 25195660
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Necroptosis and Inflammation.
    Newton K; Manning G
    Annu Rev Biochem; 2016 Jun; 85():743-63. PubMed ID: 26865533
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 24(S)-Hydroxycholesterol induces RIPK1-dependent but MLKL-independent cell death in the absence of caspase-8.
    Vo DK; Urano Y; Takabe W; Saito Y; Noguchi N
    Steroids; 2015 Jul; 99(Pt B):230-7. PubMed ID: 25697054
    [TBL] [Abstract][Full Text] [Related]  

  • 13. RIPK1 inhibits ZBP1-driven necroptosis during development.
    Newton K; Wickliffe KE; Maltzman A; Dugger DL; Strasser A; Pham VC; Lill JR; Roose-Girma M; Warming S; Solon M; Ngu H; Webster JD; Dixit VM
    Nature; 2016 Dec; 540(7631):129-133. PubMed ID: 27819682
    [TBL] [Abstract][Full Text] [Related]  

  • 14. RIPK1 and RIPK3 Kinases Promote Cell-Death-Independent Inflammation by Toll-like Receptor 4.
    Najjar M; Saleh D; Zelic M; Nogusa S; Shah S; Tai A; Finger JN; Polykratis A; Gough PJ; Bertin J; Whalen M; Pasparakis M; Balachandran S; Kelliher M; Poltorak A; Degterev A
    Immunity; 2016 Jul; 45(1):46-59. PubMed ID: 27396959
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activity of protein kinase RIPK3 determines whether cells die by necroptosis or apoptosis.
    Newton K; Dugger DL; Wickliffe KE; Kapoor N; de Almagro MC; Vucic D; Komuves L; Ferrando RE; French DM; Webster J; Roose-Girma M; Warming S; Dixit VM
    Science; 2014 Mar; 343(6177):1357-60. PubMed ID: 24557836
    [TBL] [Abstract][Full Text] [Related]  

  • 16. RIPK3-driven cell death during virus infections.
    Upton JW; Shubina M; Balachandran S
    Immunol Rev; 2017 May; 277(1):90-101. PubMed ID: 28462524
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intratumoral activation of the necroptotic pathway components RIPK1 and RIPK3 potentiates antitumor immunity.
    Snyder AG; Hubbard NW; Messmer MN; Kofman SB; Hagan CE; Orozco SL; Chiang K; Daniels BP; Baker D; Oberst A
    Sci Immunol; 2019 Jun; 4(36):. PubMed ID: 31227597
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulatory mechanisms of RIPK1 in cell death and inflammation.
    Liu Z; Chan FK
    Semin Cell Dev Biol; 2021 Jan; 109():70-75. PubMed ID: 32616439
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Complementary roles of Fas-associated death domain (FADD) and receptor interacting protein kinase-3 (RIPK3) in T-cell homeostasis and antiviral immunity.
    Lu JV; Weist BM; van Raam BJ; Marro BS; Nguyen LV; Srinivas P; Bell BD; Luhrs KA; Lane TE; Salvesen GS; Walsh CM
    Proc Natl Acad Sci U S A; 2011 Sep; 108(37):15312-7. PubMed ID: 21876153
    [TBL] [Abstract][Full Text] [Related]  

  • 20. RIPK1-dependent apoptosis bypasses pathogen blockade of innate signaling to promote immune defense.
    Peterson LW; Philip NH; DeLaney A; Wynosky-Dolfi MA; Asklof K; Gray F; Choa R; Bjanes E; Buza EL; Hu B; Dillon CP; Green DR; Berger SB; Gough PJ; Bertin J; Brodsky IE
    J Exp Med; 2017 Nov; 214(11):3171-3182. PubMed ID: 28855241
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.